Mint Tower Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Mint Tower Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,000	Closed	-$1.41M	–	224
2025 Q2	$1.41M	Buy	+30,000	New	+$1.33M	0.21%	62

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mint Tower Capital Management's SWTX Position: Q3 2025 in Review

Mint Tower Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 30,000 shares — an estimated $1.41M sold.

Mint Tower Capital Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $1.41M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Mint Tower Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Mint Tower Capital Management sold 30,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.41M.
Mint Tower Capital Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Mint Tower Capital Management's SpringWorks Therapeutics position peaked at $1.41M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Mint Tower Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.